[1]
A. H. Norman, D. J. Hunter, and A. J. Russell, “Linking high-risk preventive strategy to biomedical-industry market: implications for public health”, Saúde Soc., vol. 26, no. 3, pp. 638–650, Sep. 2017, doi: 10.1590/s0104-12902017172682.